Business
GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
CHICAGO, April 29, 2026--GE HealthCare (Nasdaq: GEHC) announced today a strategic evolution to its operations and executive leadership team to help shape the company’s next chapter of growth and better serve patients and customers globally. The changes will also position the company to enhance execution, accelerate innovation, and create efficiencies. These changes are effective immediately.
About this update from Ge Healthcare Technologies Inc.
[{"type":"text","content":"CHICAGO, April 29, 2026--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today a strategic evolution to its operations and executive leadership team to help shape the company’s next chapter of growth and better serve patients and customers globally. The changes will also position the company to enhance execution, accelerate innovation, and create efficiencies. These changes are effective immediately.","length":411,"tagName":"p"},{"type":"text","content":"Phil Rackliffe has been appointed President and Chief Executive Officer of Advanced Imaging Solutions (AIS), a new segment that combines Imaging and Advanced Visualization Solutions (AVS) to create a $14.6 billion segment.1 This combination brings together GE HealthCare’s two largest segments to create a more focused and connected end-to-end imaging ecosystem spanning diagnosis, intervention, and follow-up across disease states. AIS includes an AI-enabled portfolio of MR, CT, Molecular Imaging, Women’s Health, X-ray, Ultrasound, Image-guided solutions, and enterprise imaging. These solutions enable more seamless workflows, faster and more precise decision-making, and real-time procedural support. Pharmaceutical Diagnostics (PDx) and Patient Care Solutions (PCS) will continue to operate as separate segments.","length":818,"tagName":"p"},{"type":"text","content":"Catherine Estrampes has been appointed Chief Commercial and Growth Officer for GE HealthCare and will lead Global Markets, a new region that encompasses every market except for China, which continues to be led by Will Song. The creation of Global Markets will strengthen how commercial teams build and scale expertise across markets and bring the full portfolio to customers globally.","length":384,"tagName":"p"},{"type":"text","content":"Both leaders bring decades of experience advancing medical technology innovation and leading high-performing teams at global scale. These changes are designed to streamline the organization, while expanding the reach of the company’s D3 strategy—integrating smart devices and pharmaceuticals, enabled by AI and cloud across disease states—to help deliver more comprehensive, precision care worldwide.","length":400,"tagName":"p"},{"type":"text","content":""Building on the progress we’ve made since our spinoff, we are simplifying how we operate and positioning ourselves to serve cus...